Home › Activist investors › Cove Street Capital
Campaign activist. Positions and campaigns from Cove Street Capital’s SEC filings. Updated November 20, 2026.
No active campaign by this definition (see How to read this).
| Company | Stake | Source | First disclosed | Last change | Since previous filing | Flags | Stated intent |
|---|---|---|---|---|---|---|---|
| Research Solutions, Inc. | 5.9%1,907,961 shares | Schedule 13D/A, filed Dec 5, 2024 | Aug 15, 2023 | Decreased Dec 5, 2024 | ▼ 1.47 pts | — | Seeks changes or engagement |
Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.
Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.
“…engaging in discussions with stockholders of the Issuer or other third parties about the Issuer and the Reporting Persons’ investment, including potential business combinations or dispositions involving the Issuer or certain of its businesses, making recommendations or proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition), potential business combinations or dispositions involving…”
Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.
| Company | Outcome or last status | Date | First filing | Highest stage | Filings | Meeting / votes |
|---|---|---|---|---|---|---|
| Wright Investors Service Holdings, Inc. | No campaign filings in the last 12 months | Jun 18, 2019 | Mar 25, 2019 | Soliciting material filed | latest (2) | — |
| Company | Last stake | Source | Outcome | Date |
|---|---|---|---|---|
| Lifecore Biomedical, Inc. \de\ | 5.2% | Schedule 13D/A, filed Aug 15, 2023 | Not in the 13F for the quarter ended Dec 31, 2024 | Feb 12, 2025 |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
No proxy contest has gone to a vote since July 1, 2023.
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| Wright Investors Service Holdings, Inc. | No outcome in the filings read | — | Jun 18, 2019 | Mar 25, 2019 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 2 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Cove Street Capital’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.
| Holder | Form | Date | Stake |
|---|---|---|---|
| 22NW | Schedule 13D | Jun 28, 2023 | 6.7% |
| Legion Partners | Schedule 13D | Jan 4, 2024 | 17.3% |